One of two AHF laminitis research grants for 2016 will be awarded to Penn Vet Senior Research Investigator, Hannah Galantino-Homer, VMD, PhD. Her proposed study, "Epidermal stress in the pathogenesis and diagnosis of endocrinopathy-associated laminitis" was selected from a group of submissions.
Dr. Galantino-Homer's research team will include co-investigators Lynne Cassimeris of Lehigh University, Julie Engiles of Penn Vet, and Robert Clark of Cumberland County College.
The most common risk factors for laminitis in horses are excess pasture, obesity, and diseases that affect the horse’s metabolism, including equine Cushing’s disease and equine metabolic syndrome. These diseases and equine obesity share common features with human pre-diabetes/metabolic syndrome.
|Penn Vet's Hannah Galantino- |
Homer will conduct her
research at New Bolton Center.
Several theories of how insulin causes endocrinopathy-associated laminitis (EAL) have been suggested in equine research. However, efforts to pinpoint the exact mechanism have been elusive.
The Laminitis Discovery Database
The investigators on this project have been applying their combined expertise in laminitis research, veterinary pathology, cell biology, protein biochemistry and histopathology to the complex problem of EAL through the use of the Laminitis Discovery Database. This “database” is the group’s archive of samples and information from naturally-occurring and experimental laminitis cases and controls. These data and samples have been collected for several years.
Background on this project
Previous molecular studies of the hyperinsulinemia model of laminitis at Penn Vet revealed changes in lamellar tissue that were consistent with over-stimulation of cellular processes. This over-stimulation leads to cell and tissue stress, damage, and loss of mechanical integrity, consistent with the failure of digital support that is the hallmark of laminitis.
The Penn Vet group became interested in how their results compare to the literature on an increasing number of metabolic, degenerative, and inflammatory human diseases in which chronic overstimulation of cellular processes leads to cell death, tissue damage and ultimately, an inflammatory response to the tissue damage. The group documented molecular evidence of cell overstimulation and cell stress in naturally-occurring EAL cases from the Laminitis Discovery Database.
They also detected changes in the same markers of cell overstimulation and stress that have been found to mediate several important human diseases and that are targets for drugs that could be applied to the prevention and treatment of EAL.
Why is this study needed to improve prevention or treatment of laminitis?
This study will allow the group to determine if the processes already documented in the Laminitis Discovery Database are important at the earliest stages of EAL. They will also determine if the lamellar tissue damage caused by EAL results in the release of keratin proteins into the blood; these proteins could serve as diagnostic biomarkers for laminitis.
What is the direct benefit of this study?
This knowledge would help in the early diagnosis of EAL and in determining the extent of lamellar tissue damage in affected horses. This study will improve our understanding of why EAL occurs, and it will open new doors to the prevention, treatment, and diagnosis of this common and devastating disease.
Congratulations to Dr. Galantino-Homer and her team.